For research use only. Not for therapeutic Use.
(rac)-Viloxazine-d5 hydrochloride（Cat No.:S000391） is a deuterated version of viloxazine hydrochloride, where five hydrogen atoms are replaced with deuterium. This modification increases the drug’s stability, aiding in detailed pharmacokinetic and metabolic research. Viloxazine is a bicyclic antidepressant previously used in some European countries and more recently approved in the United States as a treatment for attention deficit hyperactivity disorder (ADHD) in pediatric patients. It functions as a selective norepinephrine reuptake inhibitor. The hydrochloride salt enhances solubility, and the deuterated version, (rac)-Viloxazine-d5 hydrochloride, allows for more precise metabolic studies.
| Catalog Number | S000391 |
| CAS Number | 1276483-10-3 |
| Molecular Formula | C13H15D5ClNO3 |
| Purity | ≥95% |
| IUPAC Name | 2-[[2-(1,1,2,2,2-pentadeuterioethoxy)phenoxy]methyl]morpholine;hydrochloride |
| InChI | InChI=1S/C13H19NO3.ClH/c1-2-15-12-5-3-4-6-13(12)17-10-11-9-14-7-8-16-11;/h3-6,11,14H,2,7-10H2,1H3;1H/i1D3,2D2; |
| InChIKey | HJOCKFVCMLCPTP-LUIAAVAXSA-N |
| SMILES | CCOC1=CC=CC=C1OCC2CNCCO2.Cl |
